Product Information
LOSARTAN POTASSIUM 25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0260 per EA under NDC 33342004407. Its NADAC has been published 311 times since Sep 11, 2019.
FDA first approved this application on May 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342004407
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202230FDA Approved
5/30/2012
TE Code
AB
On Market Since
5/10/2012
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN POTASSIUM 25 MG TAB has been published 311 times since Sep 11, 2019, and over the history we have for it it has declined 50.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0260 per EA |
|---|---|
| All-time high | $0.0892 (Aug 12, 2020) |
| All-time low | $0.0242 (Nov 20, 2024) |
| Median price | $0.0500 |
| Average price | $0.0499 |
| Largest weekly change | -19.0% (Nov 20, 2024) |
| Weeks tracked | 311 |
| Tracking since | Sep 11, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-25.5%
5Y
-53.9%
All
-50.8%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Losartan potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOSARTAN POTASSIUM 25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.0260 per EA (NDC 33342004407), effective Aug 20, 2025.
How has the price of LOSARTAN POTASSIUM 25 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 25 MG TAB has declined 50.8%. It has been tracked across 311 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 25 MG TAB?
Since Sep 11, 2019, the NADAC for LOSARTAN POTASSIUM 25 MG TAB has ranged from a low of $0.0242 (Nov 20, 2024) to a high of $0.0892 (Aug 12, 2020), with a median of $0.0500 per EA.
Are there cheaper alternatives to LOSARTAN POTASSIUM 25 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 25 MG TAB, is $0.0218 per EA — about 16% below LOSARTAN POTASSIUM 25 MG TAB.
Who manufactures LOSARTAN POTASSIUM 25 MG TAB?
LOSARTAN POTASSIUM 25 MG TAB (NDC 33342004407) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.